Ali Sleiman – General Manager, AbbVie Egypt & Levant
AbbVie’s GM for Egypt & Levant, Ali Sleiman, explains the factors behind the stellar growth that has made the cluster one of the company’s fastest-growing global markets in 2021. He…
AbbVie aims to advance patient care globally across six therapeutic areas: immunology, kidney disease, liver disease, neuroscience, oncology, and women’s health. With a rich, 125-year heritage of developing pharmaceuticals, AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. A global enterprise that serves patients in more than 170 countries, AbbVie launches in the United Arab Emirates with a strong commitment to the region’s healthcare.3
Contact
90th Street, Plot 76, 1st Sector, 5th Settlement, New Cairo, P.O.: 11835, Egypt, 5th Settlement, Cairo
Tel: (20-2) 2614-5800
Fax: 26145891
Web: abbvie.com
AbbVie’s GM for Egypt & Levant, Ali Sleiman, explains the factors behind the stellar growth that has made the cluster one of the company’s fastest-growing global markets in 2021. He…
Abbvie has taking a leading role in the Egyptian pharmaceutical industry by bringing their new all-oral hepatitis C treatment to Egypt, the country with the highest prevalence of the disease…
Five days before the January 25th revolution of 2011, Rameda changed ownership and CEO Amr Morsy set out to turn-around the mismanaged business. Five years later, revenues are up 4.5…
Tabuk Pharmaceuticals, the largest private Saudi pharmaceutical company with commercial operations in 25 countries in middle east and 5 European countries with a portfolio of more than 250 products, chose…
Egypt can boast some of the most modern manufacturing sites in the Arab world. The CEO of Future Pharmaceutical Industries discusses the importance of promoting exports, the ambitious plans of…
Starting as a pharmacy chain, Hefny Pharma Group has developed into a group focused on manufacturing, importing and distributing pharmaceutical products to the Egyptian market, with an eye on the…
The chairman of Egypt’s largest holding company for pharmaceutical manufacturers, ACDIMA, shares his vision for how Egyptian manufacturers can enhance their competitiveness in the coming years, and extend their activities…
Marcyrl grew 40 percent and jumped from 15th to 9th place in the Egyptian market in 2014. With growth remaining strong, the board explains the keys to success for doing…
With a large and growing population, and significant domestic health needs, Lilly Egypt general manager Ozkan Ozdogan sees many opportunities for various stakeholders to serve patients, and is focusing on…
Servier Egypt’s recently arrived general manager shares his first impressions and assessments of the Egyptian business environment, and discusses the potential he sees for Servier Egypt to build upon its…
OrganoPharma’s founder and chairman Dr. Mowfak Sakr explains how he founded his company to try and provide the 40 million people in Egypt who lack healthcare insurance of any kind…
Phyto-Pharmaceuticals often offer better, more sustainable treatment solutions than synthetic pharmaceuticals, explains the Sekem group’s CEO Helmy Abouleish. Atos Pharma’s CEO Ashraf Mamdouh expands on the companies current plans for…
Medical Union Pharmaceuticals (MUP) acquired Lilly’s Egyptian human insulin vial manufacturing facility in early 2015. Managing Director Ahmed Kelani discusses the national significance of this acquisition given Egypt’s high prevalence…
As the founder of Egypt’s leading commercial agent for advanced medical technologies, Mahmoud Bagneid has a simple goal for Egyptian healthcare; for all Egyptian’s to be aware that they should…
See our Cookie Privacy Policy Here
